Hypothesis

2 Matching Annotations

May 2024
aacrjournals.org aacrjournals.org

A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma

2
1. scibot 23 May 2024
  
  in Public
  
  RRID: SCR_014043
  
  DOI: 10.1158/1078-0432.CCR-23-3249
  
  Resource: Cytobank (RRID:SCR_014043)
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_014043
  
  What is this?
  
  DOI:10.1158/1078-0432.CCR-23-3249 RRID:SCR_014043
2. scibot 23 May 2024
  
  in Public
  
  RRID: SCR_024202
  
  DOI: 10.1158/1078-0432.CCR-23-3249
  
  Resource: SCR_024202
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_024202
  
  What is this?
  
  RRID:SCR_024202 DOI:10.1158/1078-0432.CCR-23-3249
Visit annotations in context

Tags

RRID:SCR_014043

RRID:SCR_024202

DOI:10.1158/1078-0432.CCR-23-3249

Annotators

scibot

URL

aacrjournals.org/clincancerres/article/30/10/2097/745179/A-Phase-II-Open-Label-Randomized-Clinical-Trial-of